The short answer
Ozempic's list price (WAC) is roughly $935 per month for the standard maintenance dose. But the number on your pharmacy receipt depends on whether you use a manufacturer coupon, go through a telehealth program, or opt for compounded semaglutide instead. In practice, uninsured patients in 2026 pay anywhere from $149 to $935 per month.
This guide breaks down every pricing tier and tells you exactly which path makes sense for your situation.
What determines Ozempic's price?
Ozempic (semaglutide 0.25 mg–2 mg injection) is manufactured by Novo Nordisk. It's FDA-approved for type 2 diabetes, not obesity — which means insurers sometimes cover it for diabetes but deny it for weight loss.
The cash price is set by three layers:
1. Wholesale Acquisition Cost (WAC) — what Novo Nordisk charges distributors. Currently ~$935/month. 2. Pharmacy markup — varies by pharmacy. Big chains (CVS, Walgreens) tend to charge close to WAC. Mark Cuban's Cost Plus Drugs and some independents undercut by 10–20%. 3. Savings programs — Novo Nordisk's own NovoCare program and third-party discount cards (GoodRx, RxSaver) can shave $50–$300 off the sticker depending on the pharmacy.
Price breakdown by path
Brand-name Ozempic at retail
Without any coupons or savings cards, expect to pay $890–$970 per month depending on the pharmacy and your dose. This is the worst-case scenario and almost never the smartest move.
Brand-name with NovoCare savings card
Novo Nordisk offers a savings card through NovoCare that can reduce your cost to roughly $500–$550/month if you don't have commercial insurance. The card is not available to Medicare, Medicaid, or TRICARE patients.
Brand-name through telehealth (Ro, Hims, PlushCare)
Telehealth programs negotiate bulk pricing. Typical cost: $299–$449/month including the consultation fee and medication. This is often the simplest option — one subscription covers the prescriber visit and the drug.
[program:ro]
Compounded semaglutide
Compounded versions of semaglutide (not the Novo Nordisk brand) are available through licensed 503B compounding pharmacies. These are FDA-regulated facilities making the same active ingredient but without the brand packaging.
Typical cost: $149–$299/month depending on the dose and program. Mochi Health, Hims, and several other programs offer compounded semaglutide at this range.
[program:mochi-health]
Important caveat: the FDA's position on compounded GLP-1s has shifted multiple times. As of April 2026, compounded semaglutide remains available under the FDA's enforcement discretion while supply shortages are resolved. This could change. Always confirm with your provider that their compounding pharmacy holds a valid 503B license.
International or Canadian pharmacies
Some patients order from licensed Canadian pharmacies at $300–$450/month. This is legal for personal use under FDA enforcement discretion, but there are risks: cold-chain shipping is critical for injectables, and not all online pharmacies are legitimate.
We don't recommend this route unless you've verified the pharmacy through PharmacyChecker or CIPA (Canadian International Pharmacy Association).
How to lower your Ozempic cost
1. Ask your prescriber about Wegovy instead
If your goal is weight loss (not diabetes management), Wegovy is the same active ingredient (semaglutide) but FDA-approved for obesity. Some insurers cover Wegovy for obesity even when they deny Ozempic for the same purpose. It's worth checking.
2. Use the NovoCare savings card
Even if the savings aren't dramatic, the card is free and takes 60 seconds to activate at novocare.com.
3. Compare pharmacy prices
GoodRx, RxSaver, and Cost Plus Drugs often show prices $50–$150 below the big-chain retail price. Always check before filling.
4. Consider a telehealth program
Programs like Ro, Hims, and PlushCare bundle the prescriber visit and medication into a single monthly fee. For uninsured patients, this is often cheaper than paying a primary care copay plus full-price medication separately.
5. Ask about compounded semaglutide
If budget is the primary constraint and you're comfortable with a non-branded version, compounded semaglutide through a 503B pharmacy is the lowest-cost option currently available.
6. Appeal an insurance denial
If you have insurance but were denied, it may be worth appealing. Prior authorization denials for GLP-1s are overturned roughly 40–50% of the time on first appeal.
Is Ozempic worth the cost without insurance?
This depends entirely on your situation. The clinical data is unambiguous: semaglutide produces 10–14% average weight loss in the STEP trials, with meaningful improvements in cardiovascular risk factors, A1C, and blood pressure.
The question is whether the monthly cost is sustainable for you over the 12–24 months most patients need to see full results. GLP-1 medications work best as a long-term treatment, not a short-term fix — and regain after stopping is common.
If $300+/month is a stretch, compounded semaglutide at $149–$199 may be a more realistic entry point. If even that is too much, the oral Wegovy pill (approved January 2026) may offer a lower price point as competition heats up.
What about generic Ozempic?
There is no generic semaglutide approved in the United States as of April 2026. Novo Nordisk's patents on semaglutide extend into the early 2030s. Generic competition is not expected before 2031–2032 at the earliest.
Compounded semaglutide is sometimes described as "generic Ozempic" in marketing, but this is technically inaccurate — compounded drugs are not FDA-approved generics. They're individually compounded preparations of the same active ingredient.
Our bottom line
Nobody should pay $935/month for Ozempic out of pocket. Between telehealth programs, compounded versions, and savings cards, uninsured patients in 2026 can realistically expect to pay $149–$449/month for semaglutide. The right number for you depends on whether you want brand-name medication and how much clinical support you need around it.
Start with our program comparison to find the path that fits your budget and goals.